Steven Ryder
Chief Tech/Sci/R&D Officer at RALLYBIO CORPORATION
Net worth: 317 411 $ as of 30/04/2024
Profile
Steven W.
Ryder is currently a Director at Biotechnology Innovation Organization, Director at Levo Therapeutics, Inc., and Chief Medical Officer at Rallybio Corp.
Previously, he served as an Independent Director at Reata Pharmaceuticals, Inc. from 2022 to 2023, Chief Development Officer at Alexion Pharmaceuticals, Inc. from 2013 to 2018, President at American Society of Clinical Psychopharmacology, and President at Astellas Pharma Global Development, Inc. from 2008 to 2013.
He holds a doctorate degree from Icahn School of Medicine at Mount Sinai.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
RALLYBIO CORPORATION
0.51% | 31/03/2024 | 192,370 ( 0.51% ) | 317 411 $ | 30/04/2024 |
Steven Ryder active positions
Companies | Position | Start |
---|---|---|
RALLYBIO CORPORATION | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Director/Board Member | 01/07/2019 |
Former positions of Steven Ryder
Companies | Position | End |
---|---|---|
REATA PHARMACEUTICALS, INC. | Director/Board Member | 26/09/2023 |
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2018 |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | President | 01/04/2013 |
American Society of Clinical Psychopharmacology | President | - |
Training of Steven Ryder
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
RALLYBIO CORPORATION | Health Technology |
Private companies | 6 |
---|---|
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Levo Therapeutics, Inc.
Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
American Society of Clinical Psychopharmacology |
- Stock Market
- Insiders
- Steven Ryder